Format

Send to

Choose Destination
J Psychiatry Neurosci. 1994 Mar;19(2):114-9.

Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.

Author information

1
St. Mary's Hospital, Montréal, Quebec, Canada.

Abstract

Thirteen patients diagnosed during two menstrual cycles as suffering from late luteal phase dysphoric disorder were then followed in an open pilot study for a further three cycles. During one complete cycle, baseline levels of symptoms were obtained. During the next three cycles, the patients were treated with L-tryptophan, six grams per day. L-tryptophan treatment was associated with a significant amelioration of symptoms with only mild side effects. These data suggest that L-tryptophan should be tested at a dose of six grams of L-tryptophan per day in a placebo-controlled study in patients with late luteal phase dysphoric disorder who suffer from symptoms such as depression, irritability, insomnia and carbohydrate craving, which may respond to potentiation of serotonin function.

PMID:
8204563
PMCID:
PMC1188575
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center